Lin M, Shon IH, Wilson R et al. Treatment response in liver metastases following 90Y SIR-spheres: an evaluation with PET. Hepatogastroenterology 2007; 54 : 910–912.

Szyszko T, Khodjibekova M, Singh A, AL-Nahhas A. Role of nuclear medicine in the treatment and follow-up of unresectable liver tumours treated with yttrium-90 microspheres. RAD Magazine June 2007; 33 (385): 25.

Tehranipour N, Al-Nahhas A, Canelo R, et al. Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: Confirmation with histopathology. Clinical Nuclear Medicine 2007; 32 (5): 371–374.

Welsh JS. Radiographically identified necrosis after ⁹⁰ Y microsphere brachytherapy: A new standard for oncologic response assessment?. American Journal of Roentgenology 2007; 188: 765–767.

Keppke AL, Salem R, Reddy D et al. Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. American Journal of Roentgenology 2007; 188: 768–775.

Miller FH, Keppke AL, Reddy D et al. Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET. American Journal of Roentgenology 2007; 188: 776–783.

Burdette AS, Carlisle JG, Morton KA. Fusion of Tc-99m MAA SPECT images to CT or MR images in yttrium-90 microsphere radioembolization treatment planning. Society of Interventional Radiology 2007; Abs. 402.

Szyszko T, AL-Nahhas A, Canelo R et al. Assessment of response to treatment of unresectable liver tumours with ⁹⁰ Y microspheres: Value of FDG PET versus computed tomography. Nuclear Medicine Communications 2007; 28: 15–20.

Boppudi S, Wickremesekera S, Nowitz M et al. Evaluation of the role of CT in the assessment of response to selective internal radiation therapy in patients with colorectal liver metastases. Australasian Radiology 2006; 50: 570–577.

Denecke T, Lopez Hänninen E, Rühl R et al. Planning transarterial radioembolisation of colorectal liver metastases with Y90-microspheres: diagnostic imaging approach. European Association of Nuclear Medicine (EANM) Conference 2006; Abs. 180.

Rose SC, Iussich G, Casola G. Comparison of computed tomography-angiography and digital subtraction-angiography for displaying vascular anatomy relevant to regional therapy for liver cancers. Cardiovascular and Interventional Radiology 2006. Abs. P88.

Sebastian AJ, Szyszko T, Al-Nahhas A, Tait NP. Value of hepatic angiography and Brehmstrallung imaging in selective internal radiation therapy. Cardiovascular and Interventional Radiology 2006. Abs. P88.

Rivet M. Monitoring ⁹⁰ Y-SIRsphere treatment response with ¹⁸ FDG-PET. ANZ Nuclear Medicine 2006; September: 3–4.

Rhee TK, Omary RA, Gates V et al. The effect of catheterdirected CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. Journal of Vascular and Interventional Radiology 2005; 16: 1085–1091.

Bienert M, McCook B, Carr B et al. Sequential FDG PET/CT in ⁹⁰ Y microsphere treatment of unresectable colorectal liver metastases. European Journal of Nuclear Medicine and Molecular Imaging 2005; 32: 723.

Bienert M, McCook B, Carr B et al. ⁹⁰ Y microsphere treatment of unresectable liver metastases: changes in ¹⁸ F-FDG uptake and tumour size on PET/CT. European Journal of Nuclear Medicine and Molecular Imaging 2005; 32: 778–787.